Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4586028
Max Phase: Preclinical
Molecular Formula: C61H72I4N8
Molecular Weight: 917.30
Molecule Type: Unknown
Associated Items:
ID: ALA4586028
Max Phase: Preclinical
Molecular Formula: C61H72I4N8
Molecular Weight: 917.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCC[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.[I-].[I-].[I-].[I-]
Standard InChI: InChI=1S/C61H71N8.4HI/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-37-69-44-35-49(36-45-69)61-56-27-25-54(64-56)59(47-31-40-67(3)41-32-47)52-23-21-50(62-52)58(46-29-38-66(2)39-30-46)51-22-24-53(63-51)60(55-26-28-57(61)65-55)48-33-42-68(4)43-34-48;;;;/h21-36,38-45H,5-20,37H2,1-4H3,(H,62,63,64,65);4*1H/q+3;;;;/p-3/b58-50-,58-51-,59-52-,59-54-,60-53-,60-55-,61-56-,61-57-;;;;
Standard InChI Key: KEVYSYMOGQACHH-QEWBMAJUSA-K
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 917.30 | Molecular Weight (Monoisotopic): 916.5858 | AlogP: 13.35 | #Rotatable Bonds: 21 |
Polar Surface Area: 72.88 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 4.74 | CX LogP: -1.88 | CX LogD: -1.88 |
Aromatic Rings: 7 | Heavy Atoms: 69 | QED Weighted: 0.06 | Np Likeness Score: 0.08 |
1. Ferino A, Nicoletto G, D'Este F, Zorzet S, Lago S, Richter SN, Tikhomirov A, Shchekotikhin A, Xodo LE.. (2020) Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins., 63 (3): [PMID:31930916] [10.1021/acs.jmedchem.9b01577] |
Source(1):